Skip to main content

Table 4 Medication data

From: Peripheral non-enzymatic antioxidants in patients with schizophrenia: a case-control study

 Remission groupAU groupPre- and post-treatment
casesdoses (mg/day)casesdoses (mg/day)casesdoses (mg/day)
Antipsychotics
 Perphenazine317.33 ± 8.33517.60 ± 11.52619.33 ± 10.86
 Sulpiride1600.00
 Risperidone455.36 ± 1.32264.52 ± 1.89534.86 ± 1.55
 Amisulpride7885.71 ± 302.379600.00 ± 300.0014650 ± 295.48
 Olanzapine1013.50 ± 2.421614.38 ± 8.391814.44 ± 4.50
 Ziprasidone2140 ± 28.28480 ± 46.192100 ± 84.85
 Quetiapine7285.71 ± 89.979327.78 ± 207.8314296.43 ± 171.49
 Clozapine13153.85 ± 96.7412176.04 ± 162.2310111.25 ± 110.62
 Aripiprazole1615.31 ± 9.742217.05 ± 7.822218.09 ± 10.08
Mood stabilizers
 Valproate3700.00 ± 255.842700.00 ± 278.655675.56 ± 245.09
 Lithium2425.00 ± 206.161560.00 ± 251.003478.57 ± 191.17
 Lamotrigine137.50
Antidepressants
 Escitalopram310.00 ± 5.00410 ± 4.08
 Fluvoxamine175
 Sertraline250.00560.00 ± 22.36350.00
 Paroxetine240.00120.00
 Trazodone150.00
  1. AU antipsychotics-use